CIK 0001839970 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
BlossomHill Therapeutics, Inc.
Sign in to watch- Ticker
- BLSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851578711
- Phone
- 858-732-3880
- Business address
- 10255 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO, CA
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | GORDON CARL L Director | Conversion | +1,039,996 | 1,039,996 | ||
| 2026-08-10 | GORDON CARL L Director | Conversion | +1,049,283 | 2,089,279 | ||
| 2026-08-10 | GORDON CARL L Director | Purchase | +625,000 | $16.00 | $10.0M | 2,714,279 |
| 2026-08-10 | GORDON CARL L Director | Conversion · Series A Preferred Stock | −1,039,996 | 0 | ||
| 2026-08-10 | GORDON CARL L Director | Conversion · Series B Preferred Stock | −1,049,283 | 0 | ||
| 2026-08-10 | ORBIMED ADVISORS LLC Director | Conversion | +1,039,996 | 1,039,996 | ||
| 2026-08-10 | ORBIMED ADVISORS LLC Director | Conversion | +1,049,283 | 2,089,279 | ||
| 2026-08-10 | ORBIMED ADVISORS LLC Director | Purchase | +625,000 | $16.00 | $10.0M | 2,714,279 |
| 2026-08-10 | ORBIMED ADVISORS LLC Director | Conversion · Series A Preferred Stock | −1,039,996 | 0 | ||
| 2026-08-10 | ORBIMED ADVISORS LLC Director | Conversion · Series B Preferred Stock | −1,049,283 | 0 | ||
| 2026-08-10 | Liptak Vincent Paul General Counsel | Purchase | +2,200 | $16.00 | $35K | 111,412 |
| 2026-08-10 | Liptak Vincent Paul General Counsel | Conversion | +22,687 | 22,687 | ||
| 2026-08-10 | Liptak Vincent Paul General Counsel | Conversion · Series B Preferred Stock | −22,687 | 0 | ||
| 2026-08-10 | Agrawal Sundeep Director | Conversion | +578,524 | 578,524 | ||
| 2026-08-10 | Agrawal Sundeep Director | Conversion · Series B Preferred Stock | −578,524 | 0 | ||
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion | +1,600,682 | 1,600,682 | ||
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion | +113,435 | 1,714,117 | ||
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion | +124,779 | 124,779 | ||
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion · Series Angel Preferred Stock | −1,600,682 | 0 | ||
| 2026-08-10 | Cui Jingrong Jean President and CEO | Conversion · Series B Preferred Stock | −113,435 | 0 |
Page 1 of 3 · 43 trades